The article highlights Walgreens' financial difficulties, including an unsustainable dividend yield not covered by free cash flow. Legal fees and operational costs are significant concerns. Although management is making progress with cost-cutting and debt reduction, these efforts will take years to impact the company's financial health. This suggests a negative short-term impact on the stock price.